Sun Pharmaceuticals
Sun Pharma extends Taro tender offer
16 July 2008
Mark Mobius objects to Sun's acquisition of Taro
16 July 2008
Taro advises shareholders against Sun's open offer
11 July 2008
Sun goes ahead with Taro acquisition; files suit in US court
26 June 2008
Taro sues Sun Pharma again; alleges plan to block sale of Irish arm
20 June 2008
Taro selling Irish assets to thwart merger: Sun Pharma
06 June 2008
Sun Pharma warns of legal action against Taro for stalling merger
29 May 2008
Israel's Taro to terminate merger with Sun Pharmaceutical
28 May 2008
Sun Pharma gets US FDA approval to market generic Cerebyx
20 March 2008
USFDA approves Sun Pharmaceutical's generic cancer drug Ethyol in US markets
17 March 2008
USFDA grants tentative approval to Sun Pharma's generic anti-cancer injection Gemzar
07 March 2008
Sun Pharmaceutical buys Taro Pharma shares from Brandes
20 February 2008
Sun Pharma launches generic version of Wyeth's Protonix
30 January 2008
Sun Pharma announces settlement of litigation over generic Exelon
06 December 2007
US FDA approves Sun Pharmaceutical''s Novartis-equivalent generic Exelon capsules for US markets
24 October 2007
Ranbaxy follows Sun Pharma in demerging R&D business
19 October 2007
US FDA approves Sun Pharmaceutical'' version of Novartis''s Trileptal tablets for US sales
10 October 2007
Sun Pharmaceutical to acquire Taro Pharma for $454 million
21 May 2007
Eli Lilly sues Sun Pharma over patent for cancer drug
02 April 2007
Sun Pharma to acquire companies in the US
24 January 2007
Sun Pharma Q4 net up 26 per cent
08 June 2006
Impressive results by Sun Pharma
31 October 2005
Sun Pharma to buy manufacturing site in Hungary
11 August 2005
The rest didn''t do badly, either
16 February 2005
Sun Pharma to issue $75 million FCCB
06 December 2004
Sun Pharma launches $225 million FCCB
19 November 2004
Sun Pharmaceuticals proposes share swap with Phlox Pharma
03 August 2004
Sun Pharma plants get US regulatory clearance
28 May 2004
Two Sun Pharma units gets USFDA approval
27 May 2004
1:1 bonus from Sun Pharma
24 April 2004
Sun Pharma increases holding in Caraco
16 March 2004
Sun Pharma to increase holdings in Caraco to 60 per cent
09 February 2004
Sun Pharma logs healthy growth
03 February 2004
Sun Pharma Q1 net, sales rise
28 July 2003
Sun Pharma to invest Rs 25 cr in Jammu; posts good results
05 May 2003
Sun Pharmaceuticals approves resolutions for split, buyback
21 December 2002
Sun Pharma clocks 12% turnover, 14% PAT increase in Q2
29 October 2002
DCI team clears Sun Pharma research facility
18 September 2002
Sun Pharma sales, profit up; dividend at 50%
01 June 2002
Sun Pharma meet on merger with MJ Pharma
27 May 2002
Sun Pharma commissions Dadra plant
30 March 2002
Sun to commission Dadra plant
24 January 2002
Caraco gets FDA nod for a drug
09 January 2002
Explosion at Sun Pharma lab
08 January 2002
Sildenafil citrate drug sales surge
05 December 2001
Sun Pharma launches cure for smoking
14 August 2001
Will the ‘Sun’ rise on Caraco Pharmaceuticals?
10 April 2001
Sun Pharma announces 1:500 share swap for Pradeep Drugs
27 February 2001
Sun Pharma plans to take over Pradeep Drugs
16 February 2001
 search domain-b
  go